High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 2, 2014, Pages 174-178

  Yang, Wen ^a   Huang, Haiyan ^a   Wang, Yuzhu ^a   Yu, Xiaohong ^a   Yang, Zhijian ^a  

^a NAVY GENERAL HOSPITAL   (China)

Author keywords

BMI; Nonalcoholic fatty liver disease; Red blood cell distribution width

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AGE; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DEPENDENT VARIABLE; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE; ERYTHROCYTE VOLUME; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RED BLOOD CELL DISTRIBUTION WIDTH; RISK FACTOR; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; AGED; ANALYSIS; BLOOD; BLOOD PRESSURE; CELL SIZE; CHI SQUARE DISTRIBUTION; CHINA; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FATTY LIVER; INCIDENCE; MEAN CORPUSCULAR VOLUME; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; STATISTICAL MODEL;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CELL SIZE; CHI-SQUARE DISTRIBUTION; CHINA; CHOLESTEROL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ERYTHROCYTE INDICES; ERYTHROCYTES; FATTY LIVER; FEMALE; HEMOGLOBINS; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 84891870225     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328365c403     Document Type: Article

References (44)

1. Perlstein TS,Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009; 169:588-594
2. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009; 169:515-523
3. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50:40-47 (Pubitemid 46963527)
4. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009; 158:659-666
5. Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sánchez-Mas J, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 2009; 11:840-846
6. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117:163-168
7. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010; 105:312-317
8. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 2009; 277:103-108
9. Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 2009; 104:868-872
10. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis 2004; 24:349-362 (Pubitemid 40052626)
11. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-1428 (Pubitemid 40523737)
12. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42:44-52 (Pubitemid 40911310)
13. Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, et al. Fatty liver: an additional and treatable feature of the insulin resistance syndrome. QJM 1999; 92:73-79 (Pubitemid 29097631)
14. Seppa la-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87:3023-3028 (Pubitemid 34816338)
15. Lu Z, Zhong N. Internal medicine (published in Chinese, 567). Beijing: People's Medical Publishing House; 2010
16. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009; 32 (Suppl):s13-s61
17. Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese in Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis 2011; 12:38-44
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572 (Pubitemid 37430158)
19. Perkins SL. Examination of blood and bone marrow. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraksevas F, Glader BE, editors. Wintrobe's clinical hematology. 11th ed. Salt Lake City: Lippincott Wilkins & Williams; 2003. pp. 5-25
20. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991; 9 (Suppl 1):71-74
21. Choi SY, Kim D, Kim HJ, Kang JH, Chung SJ, Park MJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol 2009; 104:1953-1960
22. Treeprasertsuk S, Lopez-Jimenez F, Lindor KD. Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci 2011; 56:35-45
23. Nseir W, Shalata A, Marmor A, Assy N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci 2011; 56:3439-3449
24. Krawczyk M, Bonfrate L, Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2010; 24:695-708
25. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8:851-858 (Pubitemid 35012300)
26. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011-1023
27. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009; 133:628-632
28. Hellwig-Burgel T, Rutkowski K, Metzen E, Faudrey J, Jelkmann W. Interleukin-1 beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999; 94:1561-1567 (Pubitemid 29411306)
29. Macdougall IC, Cooper A. The inflammatory response and epoetin sensitivity. Nephrol Dial Transplant 2002; 17 (Suppl 1):48-52 (Pubitemid 34157120)
30. Jongen-Lavrencic M, Peeters HRM, Vreugdenhil G, Swaak AJG. Interaction of inflammatory cytokines and erythropoietin in iron metabolism and erythropoiesis in anaemia of chronic disease. Clin Rheumatol 1995; 14:519-525
31. Lee WS, Kim TY. Relation between red blood cell distribution width and inflammatory biomarkers in rheumatoid arthritis. Arch Pathol Lab Med 2010; 134:505-506
32. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Cabrera M, Sáinz JC, Fernández-Labandera C, et al. Higher red blood cell distribution width is associated with the metabolic syndrome: results of the ibermutuamur cardiovascular risk assessment study. Diabetes Care 2010; 33:e40
33. Wang T, Zhang X, Li JJ. The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol 2002; 2:1509-1520 (Pubitemid 35223232)
34. Semba RD, Patel KV, Ferrucci L, Sun K, Roy CN, Guralnik JM, et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. Clin Nutr 2010; 29: 600-604
35. Kraus A, Roth HP, Kirchgessner M. Supplementation with vitamin C, vitamin E or beta-carotene influences osmotic fragility and oxidative damage of erythrocytes of zinc-deficient rats. J Nutr 1997; 127: 1290-1296 (Pubitemid 27283994)
36. Alfthan G, Xu GL, Tan WH, Aro A, Wu J, Yang YX, et al. Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities. Biol Trace Elem Res 2000; 73:113-125 (Pubitemid 30127172)
37. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35:898-904 (Pubitemid 34258385)
38. Sanyal AJ, Campbell-Sargent C, Mirshahi F, RizzoWB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120:1183-1192 (Pubitemid 32246672)
39. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998; 114:842-845
40. Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients 2011; 3:637-682
41. Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Carten M, et al. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2012; 22:471-476
42. Das SK, Balakrishnan V. Role of cytokines in the pathogenesis of nonalcoholic fatty liver disease. Indian J Clin Biochem 2011; 26:202-209
43. Kuppan G, Anjana RM, Deepa M, Paramasivam P, Chandrakumar S, Kaliyaperumal V, et al. Inflammatory markers in relation to nonalcoholic fatty liver disease in urban South Indians. Diabetes Technol Ther 2012; 14: 152-158
44. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009; 21:504-511.